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ABSTRACT 54 
Background: Bronchopulmonary dysplasia (BPD) is one of the most common 55 
complications after preterm birth and is associated with intrauterine exposure to 56 
bacteria. Transforming growth factor (TGF)β is implicated in the development of 57 
BPD.  58 
Objectives: We hypothesized that different and/or multiple bacterial signals 59 
could elicit divergent TGFβ signaling responses in the developing lung. 60 
Methods: Time-mated pregnant Merino ewes received an intra-amniotic injection 61 
of lipopolysaccharide (LPS) and/or Ureaplasma parvum serovar 3 (UP) at 117 62 
days (d) and/or 121/122d gestational age (GA). Controls received an equivalent 63 
injection of saline and or media. Lambs were euthanized at 124d GA (term=150d 64 
GA). TGFβ1, TGFβ2, TGFβ3, TGFβ receptor (R)1 and TGFβR2 protein levels, 65 
Smad2 phosphorylation and elastin deposition were evaluated in lung tissue. 66 
Results: Total TGFβ1 and TGFβ2 decreased by 24% and 51% after combined 67 
UP+LPS exposure, whereas total TGFβ1 increased by 31% after 7d LPS 68 
exposure but not after double exposures. Alveolar expression of TGFβR2 69 
decreased 75% after UP, but remained unaltered after double exposures. 70 
Decreased focal elastin deposition after single LPS exposure was prevented by 71 
double exposures. 72 
Conclusions: TGFβ signaling components and elastin responded differently to 73 
intrauterine LPS and UP exposure. Multiple bacterial exposures attenuated TGFβ 74 
signaling and normalized elastin deposition. 75 
76 
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BACKGROUND  77 
 78 
Bronchopulmonary dysplasia (BPD), one of the most common adverse outcomes 79 
after extremely preterm birth, is characterized by arrested alveolar development 80 
resulting in fewer but larger alveoli [1]. The development of BPD is associated 81 
with pulmonary inflammation, which may result from antenatal exposure to 82 
pathogens associated with chorioamnionitis [2]. Although many different 83 
microbes have been identified in amniotic fluid [3], the most common bacteria 84 
found in the placenta and membranes of preterm infants are Ureaplasma spp [4]. 85 
Culture-positive placental tissue of 41 percent of preterm neonates delivered 86 
before 27 weeks was however polymicrobial [5]. It is unclear how this exposure to 87 
multiple bacteria affects the fetal immune response and which Toll-like receptors 88 
(TLR) process their signals. A single inflammatory and immunologic trigger will 89 
elicit variable fetal inflammatory responses in several animal models, including 90 
fetal baboons, rhesus macaques and sheep [6-9]. Interestingly, repeated 91 
exposure to lipopolysaccharide (LPS) in fetal sheep induced tolerance to a 92 
second challenge with LPS in blood and lung monocytes and suppressed TLR2, 93 
4, 5 and 9 signaling [10]. Recently, we reported that the fetal immune response to 94 
LPS was only suppressed by a long, but not short, intra-amniotic exposure to 95 
ureaplasmas in fetal sheep [11]. The interactions of the immune system with both 96 
ureaplasmas and LPS may be complex, as each is recognized by different TLRs. 97 
LPS, a cell wall component of Gram-negative bacteria, activates TLR4 by binding 98 
to the CD14 receptor, which in turn triggers myeloid differentiation factor-88 99 
(MyD88)-dependent and -independent pathways [12]. In contrast, Ureaplasma 100 
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spp. activate TLR1, 2 and 6 with cell membrane associated lipoproteins, as they 101 
lack a cell wall [13]. 102 
 103 
The links between inflammation and arrested alveolar development are a focus of 104 
ongoing experimental and clinical studies. TGFβ, an anti-inflammatory cytokine, 105 
has an ambiguous role in the pathogenesis of BPD, as it is also a growth factor 106 
for lung development and repair [14]. TGFβ is expressed in three functionally 107 
distinct isoforms,TGFβ1, TGFβ2 and TGFβ3, and is produced in a latent form 108 
which is cleaved to be activated [14]. TGFβ1 and 2 are needed for surfactant 109 
production and postnatal respiratory function, whereas TGFβ3-/- mice showed 110 
severe alveolar hypoplasia [14]. Inflammation-mediated changes in TGFβ activity 111 
may contribute to the arrested alveolar development leading to BPD [2]. Because 112 
chorioamnionitis is frequently polymicrobial, we hypothesized that different and/or 113 
multiple bacterial signals could elicit divergent TGFβ signaling responses in the 114 
developing lung. We used models of chorioamnionitis [6,11,15] in which fetal 115 
sheep received short term intra-amniotic exposures of LPS or U. parvum serovar 116 
3, or both. Expression and activation of TGFβ1, 2 and 3 and their main receptors, 117 
TGFβ receptors 1 and 2, were measured in fetal lungs. Intracellular activation of 118 
the canonical TGFβ signaling pathway was assessed by phosphorylation of 119 
mothers against decapentaplegic homolog 2 (Smad2; pSmad2 when 120 
phosphorylated), a signal transducer following coupling and activation of TGFβ 121 
receptors 1 and 2 [14].  Focal elastin deposition, crucial for secondary septation 122 
[16], was quantified to assess alveolar development.  123 
124 
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METHODS 125 
 126 
Animal model  127 
Studies were approved by the Animal Ethics Committees at The University of 128 
Western Australia and at the Cincinnati Children's Hospital Medical Center. The 129 
description of the animals has previously been published [6,11,15]. Briefly, 130 
Ureaplasmas were cultured and prepared for the intra-amniotic injections as 131 
reported [6]. Time-mated Merino ewes with singleton fetuses were randomized to 132 
ultrasound guided intra-amniotic (IA) injection of either Ureaplasma parvum 133 
serovar 3 (2x107 colony forming units) (UP) at 117 or 121 days GA and/or an IA 134 
injection of LPS (10 mg E.coli 055:B5, Sigma Chemical, St. Louis, MO, USA) at 135 
117 and/or 122 days GA (Figure 1). Controls were injected with either saline or 136 
10B media inoculums [6]. Preterm lambs were delivered and euthanized at 124 137 
days GA (term=150 days GA). Tissue from the right lower lobe (RLL) of the lung 138 
was snap frozen and the right upper lobe (RUL) was inflation-fixed at 30 cmH2O 139 
in 10% buffered formalin for 24 hours.  140 
 141 
ELISA of TGFβ1, TGFβ2 and TGFβ3 142 
Frozen RLL tissue  was homogenized (PRO Quick Connect Generators part no. 143 
02-07095; PRO Scientific Inc., Oxford, CT)  in ice-cold RIPA buffer (Sigma 144 
Aldrich) containing 0.1% protease inhibitors (Sigma Aldrich) and subsequently 145 
centrifuged at 12 rcf for 5 minutes at 4°C [17]. Free, bound and total TGFβ1, 146 
TGFβ2 and TGFβ3 (referred to by R&D Systems as active, latent and total TGFβ) 147 
were measured with ELISA kits (human TGFβ1: DY240, human TGFβ2: DY302, 148 
human TGFβ3: DY243, R&D Systems, Minneapolis, MN, USA) according to 149 
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manufacturer’s instructions [17]. TGFβ1 and TGFβ2 protein concentrations were 150 
calculated per kilogram bodyweight and reported as a mean fold change 151 
compared to controls.  152 
 153 
Immunohistochemistry  154 
Paraffin-embedded RUL sections (4 µm, transverse) were stained for TGFβ 155 
receptor 1 (TGFβR1) (ab31013, Abcam, Cambridge, UK), TGFβ receptor 2 156 
(TGFβR2) (ab28382, Abcam, Cambridge, UK) and pSmad2 (Ser465/467) 157 
(#3101, Cell Signaling Technology, Boston, USA). Sections were deparaffinized 158 
and endogenous peroxidase-activity was blocked with 0.3% H2O2 in 1x PBS (pH 159 
7.4) (for TGFβR1 and 2) or 3% H2O2 in milli-Q (for pSmad2). Antigen retrieval 160 
was performed with heated citrate buffer (10 mM, pH 6.0). Non-specific binding 161 
was blocked with 20% normal goat serum (NGS) in PBS (for TGFβR1 and 2) or 162 
5% NGS in 1x tris-buffered saline (TBS, pH 7.6) with 0.1% Tween (for pSmad2). 163 
Sections were incubated at 4°C with the primary antibody (TGFβR1: 1/100, 164 
TGFβR2: 1/500, pSmad2: 1/2000). After incubation with the secondary antibody 165 
(swine-anti-rabbit Ig*biotin, E0353, DAKO), immunostaining was enhanced with 166 
Vectastain ABC peroxidase Elite kit (PK-6200, Vector Laboratories, Burlingame, 167 
USA) and visualized with nickel sulfate-diaminobenzidine (NiDAB). The sections 168 
were rinsed and incubated with Tris/cobalt. After counterstaining with 0.1% 169 
Nuclear Fast Red, sections were washed, dehydrated and coverslipped.  170 
 171 
Evaluation was performed by light microscopy (Axioskop 40, Zeiss, Germany) 172 
with LeicaQWin Pro v.3.4.0 software (Leica Microsystems, Germany). For each 173 
animal three random locations of the section were photographed at 200x and 174 
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400x magnification. Sections were semi-quantitatively scored for positive 175 
TGFβR1, TGFβR2 and pSmad2 by ranking all sections by ascending staining 176 
intensity by a blinded observer. The scores of each experimental group were 177 
standardized to the average score of controls. 178 
 179 
Elastin staining  180 
Elastin staining was performed on RUL lung sections as described [6]. Elastin 181 
foci were counted using Image J software (Rasband, W.S., ImageJ, U.S. National 182 
Institutes of Health, Bethesda, Maryland, USA) [6], corrected for photomicrograph 183 
surface area, and expressed as elastin foci/mm2. The values of each 184 
experimental group were standardized to the average value of controls. Results 185 
for 3 and 7 day ureaplasma exposure were reported previously [6]. 186 
 187 
Data analysis 188 
Results of ELISA’s are given as means±SEM; results of immunohistochemical 189 
and histological stainings are given as median with interquartile range. For 190 
ELISA’s, groups were compared using one-way ANOVA with Dunnett’s test for 191 
post-hoc analysis. Two group comparisons were done by student T-test. For all 192 
immunohistochemical and histological analyses, groups were compared using a 193 
Kruskal-Wallis one-way ANOVA with Dunn’s test for post-hoc analysis. Two 194 
group comparisons were done by Mann-Whitney test. Statistical analysis was 195 
performed by GraphPad Prism v5.0. Significance was accepted at p<0.05. 196 
197 
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RESULTS 198 
 199 
Modulated expression of TGFβ signaling components after single intra-200 
amniotic LPS injection 201 
After LPS exposure protein levels of TGFβ2 slightly decreased at 2 days 202 
compared to controls, a result not reaching statistical significance (p=0.0516 for 203 
total TGFβ2) (Table 1). This was accompanied by a trend towards increased 204 
alveolar TGFβR2. The focal expression of elastin on secondary septa also 205 
decreased (Table 1). 206 
Seven days after LPS exposure there were increases in free and total TGFβ1 207 
and 2 levels, which was only significant for total TGFβ1. In contrast, the alveolar 208 
expression of both TGFβ receptors, pSmad2 and elastin foci were not 209 
significantly different from controls. No TGFβ3 could be detected by ELISA in 210 
protein extracts of the lungs of any lambs (data not shown). 211 
 212 
Repeated LPS exposure did not affect TGFβ expression and signaling  213 
Free and total TGFβ1 and free TGFβ2 levels in the lungs of fetal lambs exposed 214 
to repeated LPS were not significantly different from those in controls (Table 1). 215 
Total TGFβ2 levels however were decreased, similar to single 2 day LPS 216 
exposure, reaching a p-value of 0.0516 (Table 1). The intensity of both TGFβ 217 
receptors and pSmad2 was not significantly different from controls (Table 1). In 218 
contrast to single 2 day LPS exposure, elastin foci were not significantly 219 
decreased (Table 1). 220 
 221 
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Fetal colonization with U.parvum did not consistently affect TGFβ pathway 222 
members 223 
Three days after IA U.parvum injection, levels of both free and total TGFβ1 and 2 224 
remained unaffected, with no sign of pathway activity as indicated by pSmad2 225 
(Table 2). Contrasting with a single LPS injection after a similar exposure time, 226 
there was a steep decline of TGFβR2, whereas TGFβR1 immuno-intensity was 227 
unchanged. Focal elastin deposition was not significantly altered. 228 
After an incubation of 7 days, none of the tested pathway members differed 229 
significantly from levels in the lungs of controls.  230 
 231 
Simultaneous exposure to LPS and U.parvum lowered TGFβ pathway 232 
components 233 
Levels of free TGFβ1 and TGFβ2 were unchanged compared to controls after 234 
sequential exposure to U. parvum and LPS, despite a marked decrease in levels 235 
of total TGFβ1 and TGFβ2 (Table 3). Downstream of TGFβ, intensity of TGFβR1 236 
and 2 and pSmad2 was not significantly different from controls. Likewise, the 237 
density of elastin foci on secondary septa was not significantly changed.. 238 
239 
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DISCUSSION 240 
When infants are diagnosed with BPD at 28 days or 36 weeks gestational age 241 
[1], their lungs have been exposed to various potentially damaging situations. 242 
Epidemiological studies however suggest that infants exposed to intrauterine 243 
inflammation are more likely to develop BPD, but do not provide information why 244 
their lungs are more susceptible [18]. In the bronchoalveolar lavage of preterm 245 
babies increased TGFβ1-levels were identified as a marker for the development 246 
of BPD [19]. Whether intrauterine inflammation caused this increase in TGFβ1-247 
levels associated with BPD remains unclear, as clinical findings on this matter are 248 
inconsistent [20,21]. Because a variety of bacteria can induce chorioamnionitis, 249 
the nature of the intrauterine inflammation may vary. We therefore injected LPS, 250 
ureaplasmas or both to determine their effects on the TGFβ expression profile in 251 
the fetal ovine lung.  252 
 253 
There were very different outcomes for TGFβ signaling after LPS exposure when 254 
compared to ureaplasmas. Ureaplasma exposure, which caused a modest 255 
inflammatory response in fetal sheep lungs [6], only caused a marked decrease 256 
in TGFβR2 expression. In contrast, total TGFβ1 increased after LPS exposure, a 257 
stimulus which induced the immune system [15]. These effects were not apparent 258 
in lungs that were exposed to LPS twice. Remarkably, sequential exposures to 259 
ureaplasmas and LPS, decreased total TGFβ1 and 2. Elastin foci were only 260 
decreased after single LPS exposure, but not after continuous UP or sequential 261 
exposures. 262 
 263 
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The clinical implication of these findings remains to be shown. Clinical findings 264 
suggest that in utero exposure to inflammation decreases the risk of chronic lung 265 
disease and sepsis [22]. It is unclear by which mechanisms this protection is 266 
mediated but the responsiveness of immune cells may play a role. We previously 267 
showed that fetal lung exposure to inflammation matured monocytes to alveolar 268 
macrophages with adult functional properties [23]. The role and function of this 269 
cell population remains to be determined. “Mature” alveolar macrophages can 270 
provide a better protection against infectious agents, but can also initiate an 271 
inflammatory response after mechanical ventilation by activating e.g. TGFβ [14]. 272 
The outcome reported here is highly reminiscent of the immune tolerance seen in 273 
fetal lung and blood monocytes after repeated LPS exposure, in which 274 
subsequent exposure to different bacterial agents failed to elicit a second 275 
inflammatory response [10,24]. It is therefore possible that the decreased or lack 276 
of involvement of TGFβ pathway components is a direct result of immune 277 
tolerance triggered by the repeated exposures.  278 
 279 
TGFβ is implicated in the pathogenesis of BPD, but our data underline the 280 
multifactorial character of this process. Intrauterine inflammation by itself may not 281 
lead to the high levels of TGFβ as seen in BPD, but it could very well prime the 282 
fetal lung for future responses. All clinical data are based on samples obtained 283 
from ventilated infants. A frequent second hit like ventilation induced injury, 284 
postnatal sepsis or respiratory infection, could trigger an exaggerated TGFβ 285 
response leading to BPD [25]. Antenatally, the duration of bacterial exposure 286 
might also influence pulmonary TGFβ induction. Lungs of preterm lambs exposed 287 
to ureaplasmas for 70 days, with or without additional acute LPS exposure, 288 
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contained over 10-fold higher total TGFβ1 levels [11]. This suggests that long 289 
term colonization with Ureaplasma spp. of the intra-amniotic pulmonary 290 
environment could well cause the elevated TGFβ levels at birth in children that 291 
later develop BPD [19]. Whether other Gram-negative or -positive bacteria 292 
associated with chorioamnionitis would elicit a similar increase in TGFβ 293 
expression remains to be elucidated. 294 
 295 
Although our study underlines that multiple microbial exposures may have an 296 
attenuating effect on TGFβ signaling, it is subject to several limitations. Firstly, 297 
our study only looked at the effect of antenatal inflammation on TGFβ signaling in 298 
fetal lung tissue. We could not replicate the dramatic postnatal increase in TGFβ 299 
found in preterm infants developing BPD. We would therefore like to stress that 300 
the results presented here cannot be readily translated into the clinical reality. 301 
Further mechanical and clinical studies must be done to validate the significance 302 
of our findings, in which special attention should be given to the role of TGFβ2 303 
and TGFβR2. Secondly, some of our results currently only show trends, and are 304 
not statistically significant. The authors feel that these results are nonetheless 305 
biologically relevant, as they are probably a result of the small group sizes that 306 
are inherent for this large animal model. 307 
 308 
In conclusion, this study shows that TGFβ signaling components responded 309 
differently to intrauterine LPS and Ureaplasma exposure, but were decreased 310 
after exposure to both LPS and Ureaplasmas. Contrary to observations after 311 
single exposures, focal elastin deposition was unchanged after exposure to two 312 
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inflammatory mediators. This outcome may be the result of fetal immune 313 
tolerance after multiple bacterial exposures. 314 
 315 
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Table 1: Effect of single and repeat LPS exposures on TGFβ pathway 410 
components and elastin deposition 411 
 Control 2d LPS 7d LPS 2+7d LPS 
TGFβ protein levels  
TGFβ1 free 1.00±0.32 0.70±0.09 1.30±0.26 1.15±0.24 
            total 1.00±0.06 0.95±0.02 1.31±0.05* 1.09±0.09 
TGFβ2 free 1.00±0.14 0.62±0.05 1.42±0.24 0.99±0.15 
            total 1.00±0.06 0.56±0.05 1.10±0.23 0.73±0.11 
TGFβ signaling components  
TGFBR1 1.05 
[0.40-1.60] 
0.72 
[0.58-1.54] 
0.98 
[0.30-1.28] 
1.35 
[0.38-1.80] 
TGFBR2 1.02 
[0.68-1.37] 
1.73 
[1.59-1.96] 
0.59 
[0.17-1.10] 
1.01 
[0.51-1.86] 
pSmad2 0.95 
[0.47-1.62] 
1.71 
[0.41-2.39] 
2.00 
[0.82-2.94] 
1.76 
[1.06-2.47] 
Elastin 
foci/mm2 
1.03 
[0.90-1.14] 
0.59 
[0.47-0.86]* 
0.90 
[0.78-1.04] 
0.84 
[0.62-0.95] 
All values are presented as mean fold change compared to control. Data of TGFβ 412 
protein levels is expressed as mean ± SEM; data of TGFβ signaling components 413 
and elastin foci is expressed as median and interquartile range. LPS:  414 
lipopolysaccharide; d: day; TGFβ: transforming growth factor β. * p<0.05 versus 415 
controls  416 
 417 
418 
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Table 2: Effect of single U. parvum exposures on TGFβ pathway 419 
components and elastin deposition 420 
 Control 3d UP 7d UP 
TGFβ protein levels 
TGFβ1 free 1.00±0.18 1.48±0.24 1.75±0.36 
            total 1.00±0.07 1.04±0.09 0.80±0.06 
TGFβ2 free 1.00±0.08 1.14±0.27 0.87±0.15 
            total 1.00±0.08 0.88±0.11 0.74±0.07 
TGFβ signaling components 
TGFBR1 1.16 
[0.26-1.62] 
1.11 
[0.72-1.90] 
0.96 
[0.34-1.69] 
TGFBR2 0.99 
[0.70-1.37] 
0.25 
[0.13-0.38]* 
1.30 
[0.75-1.38] 
pSmad2 0.99 
[0.59-1.40] 
0.90 
[0.45-1.08] 
1.44 
[0.61-2.00] 
Elastin foci/mm2 1.01 
[0.89-1.11] 
1.27 
[1.10-1.55] 
0.93 
[0.62-1.04] 
All values are presented as mean fold change compared to control. Data of TGFβ 421 
protein levels is expressed as mean ± SEM; data of TGFβ signaling components 422 
and elastin foci is expressed as median and interquartile range. UP: Ureaplasma 423 
parvum; d: day; TGFβ: transforming growth factor β. * p<0.05 versus controls  424 
425 
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Table 3: Effect of simultaneous exposure to U. parvum and LPS on TGFβ 426 
pathway components and elastin deposition 427 
 Control 2d LPS +  7d UP 
TGFβ protein levels 
TGFβ1 free 1.00±0.06 0.97±0.11 
            total 1.00±0.09 0.76±0.05* 
TGFβ2 free 1.00±0.12 0.68±0.14 
            total 1.00±0.05 0.49±0.07* 
TGFβ signaling components 
TGFBR1 1.25 
[0.32-1.57] 
1.88 
[0.83-2.29] 
TGFBR2 1.14 
[0.50-1.43] 
0.86 
[0.29-1.43] 
pSmad2 1.25 
[0.32-1.57] 
1.88 
[0.83-2.29] 
Elastin foci/mm2 1.00 
[0.95-1.05] 
1.00 
[0.50-1.1] 
All values are presented as mean fold change compared to control. Data of TGFβ 428 
protein levels is expressed as mean ± SEM; data of TGFβ signaling components 429 
and elastin foci is expressed as median and interquartile range. UP: Ureaplasma 430 
parvum; d: day; TGFβ: transforming growth factor β. * p<0.05 versus controls  431 
 432 
433 
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Figure legends 434 
 435 
Figure 1: Study design. IA: intra-amniotic; LPS: lipopolysaccharide; UP: U. 436 
parvum; d: day; GA: gestational age 437 
 438 
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